Hepatoid adenocarcinoma of the stomach (HAS) is a rare type of gastric cancer with an extremely poor prognosis. The current study reports a rare case of HAS, characterized by gastric cancer and infiltration of cancer cells into the left liver lobe, as well as lymphadenectasis. The expression of α‑fetoprotein (AFP) was markedly increased in the tumor cells of the liver neoplasms. A gastric biopsy indicated highly, moderately and poorly differentiated papillary adenocarcinoma. The patient underwent two cycles of chemotherapy with oxaliplatin (130 mg; day 1) and capecitabine (2 mg, twice daily; days 1‑14). At 7 weeks after the chemotherapy, an expanded gastrectomy and radical resection of left lung lobe were performed on the operable lesion. AFP expression was significantly decreased following the procedure. A literature review was also conducted by searching PubMed/Medline, indicating that surgery and chemotherapy may positively affect the outcomes of HAS patients.
Background: Anal lymphomas are extremely rare. There are no relevant descriptions in professional books, and there are only a few case reports in the literature. Here, we report a new case and review the literature to summarize the clinical and pathological features of anal lymphoma. Methods: We described a case of anal lymphoma confirmed by pathological diagnosis, then searched the PubMed database, and finally selected 12 reported cases to be included in the study. We described the clinical and pathological characteristics of the patients. Results: Thirteen patients with anal lymphoma were confirmed. Seven men and six women with a median age of 50. There were four cases of HIV- and EBV-infected patients. The size of the tumor was 1–13 cm, all of which were diagnosed as B-cell lymphoma, and 61.5% were diffuse large B-cell lymphomas. Among the 13 patients, eight received chemotherapy or immunochemotherapy, two received radiotherapy, one received chemotherapy combined with radiotherapy, one received surgery, and one gave up treatment. Three patients died, and only 2 of 10 surviving patients had complete remission. Conclusion: Anal lymphoma is extremely rare. Patients with persistent abscess complicated with HIV or EBV infection should undergo pathological biopsy to exclude anal lymphoma.
Primary pulmonary meningioma (PPM) is rare, mostly asymptomatic, and difficult to recognize preoperatively. In this report, we describe two new cases of PPM and provide an updated review of the literature to enhance our understanding of PPM. The first patient was a 53-year-old woman with an asymptomatic solitary pulmonary nodule in the right lower lobe on chest computed tomography (CT). Wedge resection of the right lung was performed and histological features of benign PPM were pathologically confirmed, which was further supported by immunohistochemistry. The second patient was a 63-year-old man who had a left pulmonary nodule during routine physical examination. CT revealed a solid nodule in the outer basal segment of the left lower lobe. The patient underwent a wedge resection of the left lower lobe and mediastinal lymph node dissection. Postoperative pathology confirmed the presence of two tumors: one adenocarcinoma and one PPM. Both cases were confirmed to be benign PPM (grade I) by pathological examination, with histological subtypes of fibrous and psammomatous. Radiological imaging is crucial for the early detection of PPM, while pathological examination is necessary to confirm the diagnosis. Surgical treatment is recommended, and intraoperative frozen sections are essential for determining the extent of the operation.
Background Alpha-2-glycoprotein 1, zinc-binding (AZGP1) is a 41 kDa secreted glycoprotein that has been considered as a potential prognostic biomarker. High expression of AZGP1 in serum is considered to be an indicator of poor prognosis in CRC, however further validation in tissue specimens is lacking. Methods We detected the expression level of AZGP1 in 859 CRC patients and 210 normal mucosa samples by immunohistochemistry and analyzed the relationship between AZGP1 expression and clinicopathological parameters of CRC patients. The relationship between AZGP1 and overall survival of patients was also analyzed to verify the prognostic value of AZGP1 in CRC patients. Multivariate analysis of prognostic factors in CRC patients using Cox proportional hazards regression models. Results The high expression rate of AZGP1 in colorectal adenocarcinoma was 48.4% higher than that in adjacent mucosal tissues and 13.3% (P < 0.001). The expression level of AZGP1 was related to the depth of invasion (P < 0.001), lymph node metastasis (P = 0.023), distant metastasis (P = 0.002) and pTNM stage(P = 0.003). Univariate analysis found that histological type, differentiation, invasion, lymph node metastasis, distant metastasis, pTNM stage and AZGP1 expression were associated with the prognosis of CRC patients (all P < 0.05). Multivariate analysis suggested lymph node metastasis (95% CI: 0.331–0.775, HR: 0.506, P = 0.002), distant metastasis (95% CI: 0.126–0.293, HR: 0.192, P < 0.001) and AZGP1 (95% CI: 0.262–0.637, HR: 0.408, P < 0.001) were independent prognostic indicators. Conclusion AZGP1 is a useful indicator for predicting the prognosis of CRC. Its predictive effect is weaker than that of lymph node metastasis and distant metastasis.
Background: Signet ring cell carcinoma is a rare histological type among the various forms of colorectal cancers. Even rare is when it coexisted with neuroendocrine components in one tumor. To date, there is little literature reported case of colorectal cancer diagnosed as signet ring cell carcinoma with neuroendocrine components. Case presentation:This report presents a unique case manifested as obstructed defecation for more than one month but with negative endoscopic biopsies. Laparoscopic abdominoperineal resection was performed. Based on the postoperative pathology, the patient was finally diagnosed as signet ring cell carcinoma with neuroendocrine differentiation. Discussion and conclusions: We highlight the rare coexistence of signet ring cell carcinoma and neuroendocrine differentiation in this case. We also aim to pose the pitfalls and share lessons during our diagnosis and treatment process.
Background Alpha-2-glycoprotein 1, zinc-binding (AZGP1) is a 41 kDa secreted glycoprotein that has been considered as a potential prognostic biomarker. High expression of AZGP1 in serum is considered to be an indicator of poor prognosis in CRC, however further validation in tissue specimens is lacking. Methods We detected the expression level of AZGP1 in 859 CRC patients and 210 normal mucosa samples by immunohistochemistry and analyzed the relationship between AZGP1 expression and clinicopathological parameters of CRC patients. The relationship between AZGP1 and overall survival of patients was also analyzed to verify the prognostic value of AZGP1 in CRC patients. Multivariate analysis of prognostic factors in CRC patients using Cox proportional hazards regression models. Results The high expression rate of AZGP1 in colorectal adenocarcinoma was 48.4% higher than that in adjacent mucosal tissues and 13.3% (P<0.001). The expression level of AZGP1 was related to the depth of invasion (P<0.001), lymph node metastasis (P=0.023), distant metastasis (P=0.002) and pTNM stage(P=0.003). Univariate analysis found that histological type, differentiation, invasion, lymph node metastasis, distant metastasis, pTNM stage and AZGP1 expression were associated with the prognosis of CRC patients (all P < 0.05). Multivariate analysis suggested lymph node metastasis (95% CI: 0.331-0.775, HR: 0.506, P=0.002), distant metastasis (95% CI: 0.126-0.293, HR: 0.192, P<0.001) and AZGP1 (95% CI: 0.262-0.637, HR: 0.408, P<0.001) were independent prognostic indicators. Conclusion AZGP1 is a useful indicator for predicting the prognosis of CRC. Its predictive effect is weaker than that of lymph node metastasis and distant metastasis.